MELVILLE, N.Y., May 24 /PRNewswire/ -- Today, specialty pharmaceutical manufacturer Fougera, a division of ALTANA Inc., announced it is first-to-market with FDA-approved Metronidazole Lotion 0.75% (Rx). This product is AB-rated to MetroLotion(R) by Galderma and is indicated for the treatment of rosacea (see product package insert for full prescribing information). Metronidazole Lotion is available in a 59 ml (2 oz.) bottle.
(Photo: http://www.newscom.com/cgi-bin/prnh/20060524/NYW110 )
David Klaum, Senior Vice President, Commercial Business Operations, stated, "First-to-market Metronidazole Lotion, an important addition to Fougera's line of facial products, joins our Metronidazole Cream to give health care providers the ability to choose the topical formulation that's right for their patients. At Fougera, our focus is always on providing our customers with the quality generic products they demand, in the formulations that suit their individual needs."
As a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmics, Fougera has received more topical generic FDA approvals than any other company during the past six years. This ability to provide a continuing stream of new products benefits both health care providers and patients seeking multi-source alternatives and reduced costs.
For more information on Fougera's complete line of topicals, or any other quality Fougera product, please call Fougera Customer Service at (800) 645-9833. Or visit the company online at http://www.fougera.com.
Fougera is a leading manufacturer and distributor of a wide range of multi-source topical and ophthalmic pharmaceuticals, in both prescription and over-the-counter dosage forms.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20060524/NYW110
AP Archive: http://photoarchive.ap.org
AP PhotoExpress Network: PRN9PRN Photo Desk, email@example.comFougera
CONTACT: Julie Gross Gelfand of HLD/Blankman Public Relations for Fougera,+1-516-536-6811 or +1-212-896-3926, firstname.lastname@example.org